Detalhe da pesquisa
1.
Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery.
Nature
; 589(7843): 542-547, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33238289
2.
Diagnostic Positron Emission Tomography Imaging with Zirconium-89 Desferrioxamine B Squaramide: From Bench to Bedside.
Acc Chem Res
; 57(9): 1421-1433, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666539
3.
Exploring Aqueous Coordination Chemistry of Highly Lewis Acidic Metals with Emerging Isotopes for Nuclear Medicine.
Acc Chem Res
; 57(6): 933-944, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501206
4.
Kimberlites reveal 2.5-billion-year evolution of a deep, isolated mantle reservoir.
Nature
; 573(7775): 578-581, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554979
5.
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.
Proc Natl Acad Sci U S A
; 119(27): e2203820119, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759660
6.
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
Lancet Oncol
; 25(2): 175-183, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218192
7.
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 25(5): 563-571, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621400
8.
The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer.
Breast Cancer Res
; 26(1): 30, 2024 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378689
9.
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 385(12): 1091-1103, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161051
10.
Simultaneous Determination of Transuranium Radionuclides in Urine by Tandem Quadrupole ICP-MS/MS with Mass-Shift Mode Combined with Chemical Separation.
Anal Chem
; 96(6): 2514-2523, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289041
11.
Autophagy inhibition improves the targeted radionuclide therapy efficacy of 131I-FAP-2286 in pancreatic cancer xenografts.
J Transl Med
; 22(1): 156, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360704
12.
Moving Beyond Isothiocyanates: A Look at the Stability of Conjugation Links Toward Radiolysis in 89Zr-Labeled Immunoconjugates.
Bioconjug Chem
; 35(5): 633-637, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38656148
13.
Expression of the wheat multipathogen resistance hexose transporter Lr67res is associated with anion fluxes.
Plant Physiol
; 192(2): 1254-1267, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806945
14.
Magnetically guided surgery after primary systemic therapy for breast cancer: implications for enhanced axillary mapping.
Br J Surg
; 111(2)2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325801
15.
Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseeds.
Eur J Nucl Med Mol Imaging
; 51(6): 1558-1573, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270686
16.
Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA).
Eur J Nucl Med Mol Imaging
; 51(4): 1121-1132, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897617
17.
Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles.
Eur J Nucl Med Mol Imaging
; 51(4): 1136-1146, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040931
18.
The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 51(3): 820-827, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843598
19.
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment.
Eur J Nucl Med Mol Imaging
; 51(3): 805-819, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932560
20.
A Proof-of-Concept Study on the Theranostic Potential of 177 Lu-labeled Biocompatible Covalent Polymer Nanoparticles for Cancer Targeted Radionuclide Therapy.
Chemistry
; 30(9): e202303298, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050716